Nadolol and Urinary incontinence - a phase IV clinical study of FDA data

Summary:

Urinary incontinence is reported as a side effect among people who take Nadolol (nadolol), especially for people who are female, 60+ old, also take Paxil, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Urinary incontinence when taking Nadolol. It is created by eHealthMe based on reports of 4,096 people who have side effects when taking Nadolol from the FDA, and is updated regularly.

What is Nadolol?

Nadolol has active ingredients of nadolol. It is often used in high blood pressure. eHealthMe is studying from 4,476 Nadolol users. Check the latest studies of Nadolol.

What is Urinary incontinence?

Urinary incontinence (inability to control the flow of urine and involuntary urination) is found to be associated with 1,637 drugs and 2,517 conditions by eHealthMe. Check the latest studies of Urinary incontinence.

On Jul, 19, 2026

4,096 people reported to have side effects when taking Nadolol.
Among them, 16 people (0.39%) have Urinary incontinence.

Could Nadolol cause Urinary incontinence?

Among these 16 people:

What is the gender of people who have Urinary incontinence when taking Nadolol? *

female: 81.25 %
male: 18.75 %

What is the age of people who have Urinary incontinence when taking Nadolol? *

What are other drugs people take besides Nadolol? *

What are other side effects people have besides Urinary incontinence? *

Back Pain: 9 people, 56.25%
Gait Disturbance: 7 people, 43.75%
Stress And Anxiety: 7 people, 43.75%
Pain: 7 people, 43.75%
Dry Mouth: 7 people, 43.75%
Weight Loss: 6 people, 37.50%
Hypoaesthesia (reduced sense of touch or sensation): 6 people, 37.50%
Mouth Ulcers: 6 people, 37.50%
Metastases To Meninges (cancer spreads to meninges): 6 people, 37.50%
Metastases To Liver (cancer spreads to liver): 6 people, 37.50%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 6 people, 37.50%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 12.50%
Stress And Anxiety: 2 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
Haemosiderosis (general increase in tissue iron stores without associated tissue damage): 1 person, 6.25%
Bladder Disorder: 1 person, 6.25%
Blood Pressure Abnormal: 1 person, 6.25%
Cardiac Disorder: 1 person, 6.25%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 6.25%
Chronic Renal Failure (kidney failure): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Nadolol and have Urinary incontinence?

- Check whether Urinary incontinence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nadolol:

Nadolol (4,476 reports)

Browse all side effects of Nadolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary incontinence:

Urinary incontinence (1,637 drugs)

Browse all the conditions that are associated with Urinary incontinence:

Urinary incontinence (2,517 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nadolol (the active ingredients of Nadolol) and Nadolol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.